Blend Appoints CU Veteran Reva Rao as Head of Digital Transformation for Credit Unions
SAN FRANCISCO--(BUSINESS WIRE)--Blend Labs, Inc. (NYSE: BLND), a leading origination platform for digital banking solutions, today announced the appointment of Reva Rao as Head of Digital Transformation for Credit Unions.
Rao brings over two decades of experience in financial services, with extensive leadership roles at prominent credit unions including Travis Credit Union and Golden 1 Credit Union. Her deep understanding of credit union operations and member-centric approach will be instrumental in driving Blend's mission to help credit unions deliver exceptional digital experiences.
This appointment comes at a pivotal time as Blend continues to expand its footprint in the credit union industry and consumer banking overall. Blend is trusted by hundreds of financial institutions, including seven of the top 10 credit unions in the United States, to improve member experience, drive revenue growth and reduce operational costs across digital deposit account opening, consumer lending, and mortgage loan origination. Rao will focus on helping Blend credit union customers and partners to build their competitive edge and develop strategies to position for stronger growth.
"We are honored to have Reva join the Blend team," said Nima Ghamsari, Co-founder and Head of Blend. "Her deep credit union expertise and proven leadership in digital transformation will be invaluable not only for Blend's continued growth, but more importantly, for the credit unions we serve as they work to deliver exceptional member experiences in an increasingly digital world."
Prior to joining Blend, Rao served as Chief Lending Officer at Travis Credit Union, where she led Consumer, Mortgage and Commercial lending for the $5+ billion institution. She previously held senior executive roles at Golden 1 Credit Union as Senior Vice President of Consumer Loans, overseeing lending strategies for California's largest credit union with over $20 billion in assets.
Rao's career spans leadership positions across the financial services spectrum, including roles at Wells Fargo, where she spent over 13 years in various capacities including Channel Business Manager, and at Prosper Marketplace as Head of Home Equity Marketing. She also held senior positions at JPMorgan Chase, Greenpoint Mortgage, and Citi, developing expertise in pricing analytics, risk management, and digital product development.
"Credit unions are at the forefront of member-centric banking, and they deserve technology partners who truly understand their unique challenges and opportunities," said Rao. "Blend's unified platform approach aligns perfectly with credit unions' needs to deliver seamless, personalized experiences across all banking products. I'm excited to find new ways to help credit unions leverage innovative technologies so they can continue to build and deepen member relationships."
Blend's platform delivers end-to-end digital journeys for loan origination, account opening, and consumer onboarding, with specialized solutions for mortgages, deposits, credit cards, personal loans, auto loans, and HELOCs. Last year, financial institutions processed nearly $1.2 trillion in loan applications through Blend's platform, demonstrating the company's robust capabilities and growing influence in financial services.
About Blend
Blend Labs Inc., (NYSE: BLND) is a leading digital origination platform for banks, credit unions, and mortgage lenders. From mortgages to consumer loans to deposit accounts, Blend helps financial institutions streamline workflows, launch faster, and deliver standout customer experiences. Learn more at blend.com.
Forward-Looking Disclaimer
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements generally relate to future events, future performance or expectations and involve substantial risks and uncertainties. Forward-looking statements in this press release may include, but are not limited to, our expectations regarding our product roadmap, future products/features, the timing of new product/feature introductions, market size and growth opportunities, macroeconomics and industry conditions, capital expenditures, plans for future operations, competitive position, technological capabilities and strategic relationships, as well as assumptions relating to the foregoing. The forward-looking statements contained in this press release are subject to risks and uncertainties that could cause actual outcomes to differ materially from the outcomes predicted. In some cases, you can identify forward-looking statements by terminology such as 'may,' 'will,' 'should,' 'expect,' 'plan,' 'anticipate,' 'could,' 'would,' 'intend,' 'target,' 'project,' 'contemplate,' 'believe,' 'estimate,' 'predict,' 'potential' or 'continue' or the negative of these terms or other comparable terminology that concern Blend's expectations, strategy, plans or intentions. You should not put undue reliance on any forward-looking statements. Forward-looking statements should not be read as a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by which such performance or results will be achieved, if at all. Further information on these risks and uncertainties are set forth in our filings with the Securities and Exchange Commission. All forward-looking statements in this press release are based on information available to Blend and assumptions and beliefs as of the date hereof. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all risks and uncertainties that could have an impact on the forward-looking statements contained in this press release. Except as required by law, Blend does not undertake any obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future developments, or otherwise.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
If You Invested $10K In Weyerhaeuser Stock 10 Years Ago, How Much Would You Have Now?
Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Weyerhaeuser Co. (NYSE:WY) is a real estate investment trust, which owns or controls approximately 11 million acres of timberlands in the U.S. and manages additional timberlands under long-term licenses in Canada. The company's stock traded at approximately $31.85 per share 10 years ago. If you had invested $10,000, you could have bought roughly 314 shares. Currently, shares trade at $25.67, meaning your investment's value could have declined to $8,060 from stock price depreciation. However, Weyerhaeuser also paid dividends during these 10 years. Don't Miss: Invest Where It Hurts — And Help Millions Heal: If there was a new fund backed by Jeff Bezos offering a ? Weyerhaeuser's dividend yield is currently 3.27%. Over the last 10 years, it has paid about $13.15 in dividends per share, which means you could have made $4,128 from dividends alone. Summing up $8,060 and $4,128, we end up with the final value of your investment, which is $12,188. This is how much you could have made if you had invested $10,000 in Weyerhaeuser stock 10 years ago. This means a total return of 21.88%. However, this figure is significantly less than the S&P 500 total return for the same period, which was 237.37%. Weyerhaeuser has a consensus rating of "Buy" and a price target of $35.17 based on the ratings of 13 analysts. The price target implies around 37% potential upside from the current stock price. Trending: With Point, you can On April 24, the company announced its Q1 2025 earnings, posting adjusted EPS of $0.11, beating the consensus estimate of $0.10, and revenues of $1.76 billion, in line with expectations, as reported by Benzinga. "We delivered solid results across each of our businesses in the first quarter," said CEO Devin W. Stockfish. "In addition, we increased our quarterly base dividend for the fourth consecutive year. I'm pleased with the organization's performance, particularly in light of the uncertain macroeconomic backdrop. Turning to our outlook, we are well positioned to navigate a range of market conditions in the near term, and we remain confident about the longer-term demand fundamentals that support our businesses." Given the expected upside potential, growth-focused investors may find Weyerhaeuser stock attractive. Furthermore, they can benefit from the company's solid dividend yield of 3.27%. Check out this article by Benzinga for three more stocks offering high dividend yields. Read Next: Maximize saving for your retirement and cut down on taxes: . , which provides access to a pool of short-term loans backed by residential real estate with just a $100 minimum. Image: Shutterstock This article If You Invested $10K In Weyerhaeuser Stock 10 Years Ago, How Much Would You Have Now? originally appeared on Sign in to access your portfolio
Yahoo
6 hours ago
- Yahoo
HSBC Upgrades Dr. Reddy's Laboratories Limited (RDY) to Buy from Hold
On June 5, HSBC upgraded Dr. Reddy's Laboratories Limited (NYSE:RDY) from Buy to Hold, raising the price target to INR1,445 from INR1,235, citing an optimistic outlook for the company in terms of earnings potential and solid market standing. A worker at a biopharmaceutical facility packaging an active pharmaceutical ingredient. HSBC's updated estimates for FY2026 to FY2028 take into account the shifting market tide for semaglutide and gRevlimid. The analysts are waiting for semaglutide to be introduced in Canada, Brazil, and India at the beginning of FY2027, which is a greater leap from their prior hypothesis of a launch only in Canada by Q4 of FY2026. The analysts revised their FY2026 sales figures for Dr. Reddy's Laboratories Limited (NYSE:RDY)'s gRevlimid, noting the growing competition. The adjustment includes a 5.1% decrease in the EPS estimate for FY2026, while the EPS forecast for FY2027 and FY2028 grew by 12% to 13%. According to HSBC analysts, the expected surge in semaglutide sales will strengthen Dr. Reddy's earnings. HSBC assigned a new price target for RDY's American Depositary Receipts (ADR) as well, raising it from $14.44 to $16.90. Dr. Reddy's Laboratories Limited (NYSE:RDY) is a global pharma company based in Hyderabad, India, that makes both branded and generic medicines for a wide range of health conditions. The company operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segments. While we acknowledge the potential of RDY as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: and . Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
7 hours ago
- Yahoo
UBS Upholds Buy Recommendation on Deckers Outdoor (DECK)
On June 5, UBS analysts maintained a Buy rating on Deckers Outdoor Corporation (NYSE:DECK) with a price target of $169. The analysts expect Decker's EPS to top market estimates over the coming year as sales projections increase for its Hoka brand. They also anticipate UGG to keep up its record as a major global casual footwear brand. A customer browsing a retail store, finding the perfect footwear for their casual outfits. The analysts were confident that Deckers Outdoor Corporation (NYSE:DECK) could deliver a low double-digit compound annual sales growth. They forecast that this growth could drive Deckers' forward PE ratio over 20x, compared to the present 16.7x. The $169 price target by UBS reflects a 60% upside for DECK. The stock has plummeted nearly 47% over the last six months, which signals a buying opportunity. After discussions with company management on June 4, the analysts were optimistic about Deckers Outdoor Corporation (NYSE:DECK)'s potential for growth. Despite the market showing caution with reference to the Hoka brand's capacity to sustain robust growth, UBS believes that DECK is perfectly tackling concerns about industry competition, evolving fashion trends, and dependence on Clifton and Bondi franchises. The analysts see double-digit revenue growth for Hoka in the next few years. Deckers Outdoor Corporation (NYSE:DECK) designs and markets premium footwear and apparel worldwide with brands like UGG and HOKA. The company was established in 1973 and is headquartered in Goleta, California. While we acknowledge the potential of DECK as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: 11 Stocks That Will Bounce Back According To Analysts and 11 Best Stocks Under $15 to Buy According to Hedge Funds. Disclosure: None. Sign in to access your portfolio
